|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61K 31/553 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3173084 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16201715.6 |
| Date of filing the European patent application | 2006-11-09 | |
| (97) | Date of publication of the European application | 2017-05-31 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 05110656 | 2005-11-11 | EP |
| (72) |
SOLCA, Flavio, DE
AMELSBERG, Andree, DE
STEHLE, Gerd, DE
VAN MEEL, Jacobus C. A., DE
BAUM, Anke, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173, 55216 Ingelheim am Rhein, DE |
| (54) | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES |
| QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES |